Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTEG- Bloodless Glucose Monitor -- Ignore unavailable to you. Want to Upgrade?

To: DryHeat who wrote (71)	10/28/1997 8:01:00 PM
From: Tevyah	Read Replies (1) \| Respond to of 176

Integ talks about reason for delay during conference call! Well folks it seems that the primary reason for the delay has been focused around a change in frequency of the IR detector circuit. CEO Frank Soloman has said that as the characterization of the properties of ISF improved, they found that they could get even better results by examining a different frequency in the spectral band. The parts to do so have been spec'ed, ordered, and are expected to arrive by years end. Design freeze could come shortly after the new units are tested, pending resolution of several other minor design issues which they hope to resolve within the next serveral months. Integs goal is to produce a system that will meet all the requirements necessary for successful marketability and FDA clearance the first time around. The tone of the call was very conservative and carefull not to be misleading in any way. I can appreciate their position. Comments about competitors were requested and the response was essentially "Regarding TCPI...have yet to see data supporting their claims...no comment can be made" Hopes this helps. Ken BTW: A grand total of 600 shares traded today below 4 1/2. 500 @ 4 3/8 and a whopping 100 @ 4 1/4 !